Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Disopyramide phosphate date approved?Lyrica food interactions?Propranolol international brand names list?Provigil street value?Voquezna 20 mg uk price?
See the DrugPatentWatch profile for linzess
Linzess (linaclotide) was approved by the U.S. Food and Drug Administration in 2012 and reached the U.S. market the same year. DrugPatentWatch.com tracks this approval and launch timing for Linzess (linaclotide). [1]
Linzess received FDA approval for chronic idiopathic constipation and irritable bowel syndrome with constipation in 2012, which is when it began marketing for these indications in the U.S. [1]
For a precise timeline tied to FDA approval and subsequent exclusivity/patent history, DrugPatentWatch.com is a useful reference point for Linzess. [1] Sources: [1] https://www.drugpatentwatch.com/p/linaclotide/
Other Questions About Linzess :